FDA releases new draft social media guidance

Share this article:
FDA released two guidance documents today for manufacturers and their representatives to communicate online about prescription drugs and medical devices.

The first draft guidance focused on recommendations for risk/benefit information on services with character space limitations, like Twitter and paid search on Google or Yahoo.

The second guidance discussed how to correct third-party information related to their own prescription drugs and medical devices, and stated that all misinformation should be addressed in a visible and defined portion of a forum on the internet or social media—regardless of whether it's positive or negative.

An in-depth analysis will follow tomorrow.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.